These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12733513)

  • 1. Hyperglycemia and early reperfusion therapy.
    Tanne D; Schwammenthal Y
    Stroke; 2003 May; 34(5):1235-41. PubMed ID: 12733513
    [No Abstract]   [Full Text] [Related]  

  • 2. When is enough enough?
    Donnan GA; Davis SM
    Stroke; 2001 Nov; 32(11):2710-1. PubMed ID: 11692042
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of acute ischemic stroke: systemic or local?
    von Kummer R; Gerber J
    Ann N Y Acad Sci; 2012 Sep; 1268():79-84. PubMed ID: 22994225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bolus fibrinolytic therapy in acute myocardial infarction].
    Pinelli G; Urbinati S
    Ital Heart J Suppl; 2001 Dec; 2(12):1360-2. PubMed ID: 11838360
    [No Abstract]   [Full Text] [Related]  

  • 5. Outcomes of Thai patients with acute ischemic stroke after intravenous thrombolysis.
    Dharmasaroja PA; Dharmasaroja P; Muengtaweepongsa S
    J Neurol Sci; 2011 Jan; 300(1-2):74-7. PubMed ID: 20937509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised trials of endovascular treatment of stroke are needed.
    Schott AM
    Lancet Neurol; 2010 Jan; 9(1):30-1. PubMed ID: 20083032
    [No Abstract]   [Full Text] [Related]  

  • 7. [Thrombolytic therapy: formation and current practice of intravenous thrombolysis in acute ischemic stroke].
    Iavorskaia VA; Flomin IuV; D'olog NV; Grebeniuk AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; Suppl 15():13-27. PubMed ID: 16447549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further randomized controlled trials of tPA within 3 hours are required-not!
    Lyden PD
    Stroke; 2001 Nov; 32(11):2709-10. PubMed ID: 11692041
    [No Abstract]   [Full Text] [Related]  

  • 9. Treating as early as possible with thrombolysis is crucial, but can we do better in the sub-4.5-hour time window?
    Parsons MW
    Cerebrovasc Dis; 2011; 31(3):229. PubMed ID: 21178346
    [No Abstract]   [Full Text] [Related]  

  • 10. Hyperglycemia in thrombolysed acute ischemic stroke patients.
    Poppe AY; Hill MD
    Int J Stroke; 2011 Jun; 6(3):278; author reply 278-9. PubMed ID: 21557817
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrinolytic therapy and the impact of medication errors.
    Weinstock B
    J Invasive Cardiol; 2004 Sep; Suppl():10-4. PubMed ID: 23573664
    [No Abstract]   [Full Text] [Related]  

  • 12. Intra-arterial thrombolysis: tissue plasminogen activator and other thrombolytic agents.
    Samaniego EA; Linfante I; Dabus G
    Tech Vasc Interv Radiol; 2012 Mar; 15(1):41-6. PubMed ID: 22464301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of acute ischemic apoplexy].
    Andersen G; Krieger DW; Iversen HK
    Ugeskr Laeger; 2009 Mar; 171(13):1094. PubMed ID: 19321089
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravenous tissue plasminogen activator in central retinal artery occlusion.
    Falavarjani KG; Modarres M
    Am J Ophthalmol; 2009 Jun; 147(6):1105; author reply 1105-6. PubMed ID: 19463547
    [No Abstract]   [Full Text] [Related]  

  • 15. Guidelines for Intravenous Thrombolysis (Recombinant Tissue-type Plasminogen Activator), the Third Edition, March 2019: A Guideline from the Japan Stroke Society.
    Toyoda K; Koga M; Iguchi Y; Itabashi R; Inoue M; Okada Y; Ogasawara K; Tsujino A; Hasegawa Y; Hatano T; Yamagami H; Iwama T; Shiokawa Y; Terayama Y; Minematsu K
    Neurol Med Chir (Tokyo); 2019 Dec; 59(12):449-491. PubMed ID: 31801934
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute ischemic stroke treatment in 2007.
    Goldstein LB
    Circulation; 2007 Sep; 116(13):1504-14. PubMed ID: 17893286
    [No Abstract]   [Full Text] [Related]  

  • 17. Current indications and results of thrombolysis by intravenous recombinant tissue plasminogen activator.
    Tari Capone F; Cavallari M; Casolla B; Orzi F
    Tech Vasc Interv Radiol; 2012 Mar; 15(1):10-8. PubMed ID: 22464298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic therapies in the treatment of peripheral vascular disease: clinical experience with reteplase, a third-generation thrombolytic.
    Laird JR
    J Invasive Cardiol; 2000 Mar; 12 Suppl B():27B-32B. PubMed ID: 10731297
    [No Abstract]   [Full Text] [Related]  

  • 19. Alteplase not yet proven for acute ischaemic stroke.
    Bath P
    Lancet; 1998 Oct; 352(9136):1238-9. PubMed ID: 9788448
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke.
    Tanne D; Macko RF; Lin Y; Tilley BC; Levine SR;
    Stroke; 2006 Jul; 37(7):1798-804. PubMed ID: 16763191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.